Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients with Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis

  1. Canales, M.A.
  2. Buchholz, T.A.
  3. Bortolini, J.A.P.
  4. Fogliatto, L.M.
  5. Ishikawa, T.
  6. Izutsu, K.
  7. Salar, A.
  8. Sharman, J.P.
  9. Klingbiel, D.
  10. Pokala, S.
  11. Vorozheikina, E.
  12. Trask, P.
  13. Parreira, J.
  14. Hübel, K.
Zeitschrift:
HemaSphere

ISSN: 2572-9241

Datum der Publikation: 2023

Ausgabe: 7

Nummer: 4

Seiten: E860

Art: Brief

DOI: 10.1097/HS9.0000000000000860 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus